A report on two patients with late-onset neutropenia resulted in an uncommon adverse event following antiCD20 therapies.
ORIC is a speculative Buy. Key risks include disappointing data for phase 1 readouts 1H23, delays in the clinic and heavy competition in certain areas. Read more.
Water, airport, housing are topics in East Palo Alto City Council race – Palo Alto Daily Post The Daily Post
This post-hoc analysis was performed to evaluate immunogenicity over the long term.
Amgen has famously been called a law firm with a biotech company attached to it. And now that biotech attachment will have significantly more room to develop and grow. Right next to Genentech’s 1 DNA Way in south San Francisco, Amgen on Thursday opened the doors to a new 245,000-square-foot
The Acquired Hemophilia Treatment Market is predicted to reach US$ 11 billion by 2030 from US$ 11 billion in 2021, and to grow at a CAGR of ~5.06% between
A new spinout emerged from stealth Thursday morning, backed by big name VCs and Big Pharma veterans at the helm to try to break into a new aspect of precision oncology medicine. The biotech, Nested Therapeutics, is run by two former Genentech veterans who came to the startup after stints
Although there have been major advances in treating CLL, the disease remains incurable in most cases, so there is room for improvement,
Bicycle Therapeutics seems to have some potentially intriguing technology. See why I do not have a current recommendation on BCYC stock.
COSMIC-313 Triplet Therapy Is Active in Renal Cell Carcinoma but Toxicities Pose a Challenge The ASCO Post
The recent launches of argenx’s Vyvgart and Alexion’s Ultomiris for the treatment of generalized myasthenia gravis (gMG), a debilitating and chronic autoimmune neuromuscular disorder, have provided patients with a new mechanism of action and new dosing options to tackle their disease. With at least…
The prevalence of Metastatic Renal Cell Carcinoma has been rising since the past few years, which prompts the growing demand for the treatment options. The market is driven by the increase prevalence of cancer and the rising geriatric population. The Companies developing the potential therapies in t…
A new spinout emerged from stealth Thursday morning, backed by big name VCs and Big Pharma veterans at the helm to try to break into a new aspect of precision oncology medicine. The biotech, Nested Therapeutics, is run by two former Genentech veterans who came to the startup after stints
The
IDEAYA Biosciences stock has posted a 40% loss over the past 12 months. But click here to know the reasons why IDYA is still a Buy.
A new study may have solved a mystery surrounding Crohn’s disease, a type of inflammatory bowel disease in which immune defenses meant to attack invading microbes instead mistakenly target the body’s own digestive tract.
The Global Follicular Lymphoma Drugs Market 2022 has been recently published by the Mr Accuracy Reports The report offers a cutting edge about the Follicular Lymphoma Drugs market which helps the business strategists to make the best investment evaluation The ...
The Global Biotechnology Product Manufacturing Market provides accurate global economic and country level predictions and analysis The market report also examines the current state of the Biotechnology Product Manufacturing industry as well as predicted future growth technological advancements inves…
This detailed market study done by Quince Market Insights covers Cancer Immunotherapy Market growth potentials which can assist the stakeholders to
The $10 million expansion is centered on supporting STEM education and biotech careers in schools in South San Francisco and beyond.